14050 completed, 2969 unknown, 1760 recruiting, 1129 terminated. 9274 Not applicable, 2345 Phase 2, 2312 Phase 3, 2063 Phase 1, 2033 Phase 4.
Follow Diabetes Mellitus: new trials by email Literature Review of Diabetes Mellitus trials Research Report on Diabetes Mellitus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance Vigabatrin Pill, Placebo oral tablet - Hyperinsulinism, Insulin Resistance | Phase 2 | Withdrawn | University of Arizona | 2030-04-15 | 2025-07-30 | |
| MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention - Type 2 Diabetes, Medication Adherence | Not applicable | Not yet recruiting | University of Alabama at Birmingham | 45 | 2029-05-01 | 2026-05-20 |
| Insul-In This Together: Leveraging Family Support and Diabetes Technology for Adolescents Living With Type 1 Diabetes Insul-In This Together - Diabetes Type 1 | Not applicable | Not yet recruiting | Stanford University | 200 | 2028-01-01 | 2026-10-05 |
| Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients Tirzepatide + Standard Therapy (Intervention Group), Standard Oral Antidiabetic Drugs (OADs) - Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight | Not applicable | Not yet recruiting | Akhtar Saeed Medical and Dental College | 52 | 2027-12-12 | 2026-10-29 |
| PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study Clinical Decision Aid, Standard Care - Heart Failure, Coronary Artery Disease | Not yet recruiting | Medical College of Wisconsin | 60 | 2027-12-01 | 2026-11-03 | |
| Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes MitoQ (mitoquinol mesylate), Placebo - Type 2 Diabetes (T2DM), Endothelial Dysfunction | Not applicable | Not yet recruiting | Medical College of Wisconsin | 40 | 2027-10-01 | 2026-10-30 |
| Implementation Support for HEARTS-Based Hypertension and Diabetes Care in Guatemala HEARTS implementation support, Routine HEARTS implementation - Hypertension (HTN), Type 2 Diabetes | Not applicable | Not yet recruiting | University of Michigan | 1440 | 2027-10-01 | 2026-11-12 |
| Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus Semaglutide (Wegovy) weekly injection - Gestational Diabetes Mellitus (GDM), Metabolic Syndrome | Phase 2 / Phase 3 | Not yet recruiting | University of Massachusetts, Worcester | 226 | 2027-09-01 | 2026-09-28 |
| GLP-1 RA for Stage 1 Type 1 Diabetes Semaglutide, Placebo - Stage 1 Diabetes Mellitus, Type 1 | Phase 2 | Not yet recruiting | Children's Hospital Medical Center, Cincinnati | 15 | 2027-09-01 | 2026-02-24 |
| South Asians With Type 2 Diabetes at Risk for Depression CHW-led T2D Intervention - Type 2 Diabetes | Not applicable | Not yet recruiting | NYU Langone Health | 100 | 2027-08-01 | 2026-05-19 |
| Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health INTEGRATE-CHW, Usual Care - Hypertension (HTN), CKD - Chronic Kidney Disease | Not applicable | Not yet recruiting | Florida International University | 200 | 2027-07-15 | 2026-11-05 |
| cfMSC Therapy for Diabetes cfMSC therapy for diabetes - Type II Diabetes Mellitus | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 30 | 2027-06-30 | 2026-11-02 |
| On the Move: Center and Home-Based Exercise to Enhance Mobility in Diabetic Foot Ulcer Recovery 12-week exercise regimen, 12-week standard of care - Diabetic Foot Ulcer | Not applicable | Not yet recruiting | University of Maryland, Baltimore | 60 | 2027-06-01 | 2026-10-07 |
| Na-Phenylbutyrate VAscular Trial Sodium Phenylbutyrate, Placebo - Diabetes | Early Phase 1 | Not yet recruiting | University of Pennsylvania | 30 | 2027-06-01 | 2026-07-28 |
| A Study to Lower Blood Pressure One Year After Childbirth in Women Who Had Preeclampsia The intervention in the GESTA-SCORE study involves providing detailed feedback from vascular imaging to women who have experienced adverse pregnancy outcomes (APOs). - Adverse Pregnancy Outcomes, Cardiovascular Diseases | Not applicable | Not yet recruiting | Maternal-Infantil Vall d´Hebron Hospital | 150 | 2027-06-01 | 2026-11-03 |
| The Prevalence of Hyperglycemia in Surgical Patients With Pre-diabetes Prediabetes or Diabetes, Surgery Complications | Not yet recruiting | University of Calgary | 750 | 2027-05-01 | 2026-06-23 | |
| Trial of CGM Technology in Persons Living With Prediabetes Stelo CGM - Prediabetes | Not applicable | Not yet recruiting | Wake Forest University Health Sciences | 100 | 2027-04-01 | 2026-10-23 |
| Eye Health Intervention Study in Upper Manhattan Intervention, Usual Care - Glaucoma, Suspect, Diabetic Retinopathy | Not applicable | Withdrawn | Columbia University | 2027-04-01 | 2026-05-29 | |
| Better Care Closer to Home: Enhancing Primary and Community Care Path Active™, a smart insole system designed to reduce the risk of plantar ulceration in patients with diabetic foot disease - Diabetic Foot Disease, Recurrence | Not applicable | Not yet recruiting | Universidad Complutense de Madrid | 84 | 2027-04-01 | 2026-11-03 |
| CKM For Safe Use of SGLT2i in Type 1 Diabetes Sotagliflozin Low Dose, Sotagliflozin High Dose, Dual Continuous Glucose and Ketone Monitor - Type 1 Diabetes (T1D) | Phase 3 | Not yet recruiting | University of California, San Diego | 52 | 2027-04-01 | 2026-11-04 |
Showing 20 of 22257. Sign in to see all of them.
Diabetes Mellitus, Type 2 (10061) · Diabetes Mellitus, Type 1 (3573) · Obesity (1886) · Insulin Resistance (1190) · Hypertension (1115) · Diabetic Foot (1033) · Prediabetic State (917) · Diabetes, Gestational (831) · Cardiovascular Diseases (755) · Diabetic Retinopathy (685) · Motor Activity (639) · Overweight (550) · Diabetic Neuropathies (525) · Diabetic Nephropathies (517)
Endocrine System Diseases (22131) · Nutritional and Metabolic Diseases (20285) · Metabolic Diseases (20072) · Glucose Metabolism Disorders (20034) · Pathological Conditions, Signs and Symptoms (4279) · Immune System Diseases (3781) · Autoimmune Diseases (3581) · Vascular Diseases (3568) · Cardiovascular Diseases (3562) · Signs and Symptoms (2966) · Diabetes Complications (2735) · Body Weight (2162) · Urogenital Diseases (2154) · Nutrition Disorders (2131)
Metformin (899) · Insulin Glargine (524) · Sitagliptin Phosphate (392) · Insulin (359) · Insulin Aspart (316) · Exercise (315) · dapagliflozin (299) · semaglutide (297) · Liraglutide (268) · empagliflozin (249) · Pioglitazone (248) · Standard of Care (227) · Insulin Lispro (207) · Continuous Glucose Monitoring (196) · Insulin Detemir (192)
Novo Nordisk A/S (854) · AstraZeneca (382) · Eli Lilly and Company (325) · Sanofi (270) · Merck Sharp & Dohme LLC (196) · GlaxoSmithKline (155) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (149) · Boehringer Ingelheim (147) · University of Colorado, Denver (127) · Takeda (124) · Pfizer (115) · University of Aarhus (108) · Assiut University (100) · Brigham and Women's Hospital (99) · Emory University (95)
United States (7633) · China (1490) · Canada (1425) · Germany (1348) · United Kingdom (1169) · France (956) · Denmark (892) · Italy (803) · Spain (780) · South Korea (751) · Turkey (Türkiye) (669) · Mexico (597) · Netherlands (541) · India (533) · Poland (522)
PMID 38770818, PMID 39963952, PMID 38682786, PMID 33166419, PMID 22236356, PMID 25387217, PMID 25504028, PMID 35472672, PMID 31903692, PMID 32998732, PMID 32501595, PMID 39171639, PMID 35044568, PMID 22913891, PMID 31606880, PMID 33107592, PMID 34213819, PMID 23010561, PMID 26894924, PMID 32267058, PMID 39735417, PMID 26580237, PMID 27402391, PMID 35224730, PMID 36542287, PMID 37435938, PMID 24517339, PMID 32306296, PMID 32803882, PMID 33210751, PMID 33327727, PMID 41805697, PMID 21450987, PMID 21883806, PMID 22193143, PMID 22234149, PMID 22862847, PMID 23130654, PMID 23186975, PMID 24170235, PMID 24786834, PMID 26232910, PMID 27977934, PMID 30615985, PMID 30880443, PMID 31769496, PMID 31797522, PMID 32324065, PMID 32324082, PMID 32372382
2009 (81), 2015 (74), 2014 (69), 2017 (64), 2019 (61), 2008 (60), 2016 (56), 2018 (56), 2023 (48), 2025 (46), 2005 (34), 2004 (11), OT2HL158287 (10), P30DK111024 (10), P50MD017338 (7)